Publication | Closed Access

Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial

Mitomycin CMedicineBronchial NeoplasmVersus Mitomycin CPhase Iii MulticentreCancer TreatmentOncologyRadiation OncologyLung CancerCancer ResearchRadiologyHealth Sciences